+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Molecular Partners AG (MOLN) - Financial and Strategic SWOT Analysis Review

  • ID: 4278958
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Molecular Partners AG (Molecular Partners) is a biopharmaceutical company that offers biological drugs. The company's advanced pipeline products comprise abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet age-related macular degeneration. It develops drugs on DARPin base technology and other product candidates. Molecular Partners develops products for ophthalmic conditions, cancer, immune disorders and other indications. The company also offers clinical trial services. It has partnership with pharmaceutical companies to strengthen drug platforms through in-house development, licensing and collaboration. Molecular Partners is headquartered in Zurich, Switzerland.

Molecular Partners AG Key Recent Developments

Feb 08, 2018: Molecular Partners Reports Significant Progress of Pipeline and Preliminary Unaudited Key Financials for 2017 - Key Value Inflection Points in 2018
Nov 09, 2017: Molecular Partners expands and advances robust pipeline of DARPin therapies in oncology and ophthalmology
Oct 26, 2017: Molecular Partners: Interim Management Statement Q3 2017
Sep 19, 2017: Invitation to R&D Update of Molecular Partners on The DARPin Difference - Offering Patients a New Dimension of Protein Therapeutics
Aug 30, 2017: Molecular Partners reports key financials and corporate highlights for H1 2017: Pipeline development on track with several key milestones ahead

This comprehensive SWOT profile of Molecular Partners AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Molecular Partners AG including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Molecular Partners AG - Key Information
  • Molecular Partners AG - Overview
  • Molecular Partners AG - Key Employees
  • Molecular Partners AG - Key Employee Biographies
  • Molecular Partners AG - Key Operational Heads
  • Molecular Partners AG - Major Products and Services
  • Molecular Partners AG - History
  • Molecular Partners AG - Company Statement
  • Molecular Partners AG - Locations And Subsidiaries
  • Molecular Partners AG - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Molecular Partners AG - Business Description
  • Molecular Partners AG - Corporate Strategy
  • Molecular Partners AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Molecular Partners AG - Strengths
  • Molecular Partners AG - Weaknesses
  • Molecular Partners AG - Opportunities
  • Molecular Partners AG - Threats
  • Molecular Partners AG - Key Competitors
Section 3 - Company Financial Performance Charts
  • Molecular Partners AG - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Molecular Partners AG, Key Information
  • Molecular Partners AG, Key Ratios
  • Molecular Partners AG, Share Data
  • Molecular Partners AG, Major Products and Services
  • Molecular Partners AG, History
  • Molecular Partners AG, Key Employees
  • Molecular Partners AG, Key Employee Biographies
  • Molecular Partners AG, Key Operational Heads
  • Molecular Partners AG, Other Locations
  • Molecular Partners AG, Subsidiaries
  • Molecular Partners AG, Key Manufacturing facilities
  • Molecular Partners AG, Key Competitors
  • Molecular Partners AG, SWOT Analysis
  • Molecular Partners AG, Ratios based on current share price
  • Molecular Partners AG, Annual Ratios
  • Molecular Partners AG, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Molecular Partners AG, Performance Chart
  • Molecular Partners AG, Ratio Charts
Note: Product cover images may vary from those shown